Daniel P. Cahill, MD, PhD

home / authors / daniel-p-cahill-md-phd

Articles

Nicole A. Shonka, MD;Jay S. Loeffler, MD;Daniel P. Cahill, MD, PhD;John de Groot, MD

November 1st 2015

Intracranial neoplasms can arise from any of the structures or cell types present in the cranial vault, including the brain, meninges, pituitary gland, skull, and even residual embryonic tissue.

Management of Brain Metastases in the Era of Targeted and Immunomodulatory Therapies

Priscilla K. Brastianos, MD;Daniel P. Cahill, MD, PhD

April 15th 2015

Some targeted systemic therapies have demonstrated evidence of activity in the brain-specifically in melanoma, lung cancers, and breast cancers-and these agents warrant further study in clinical trials.

Tailored Therapy in Diffuse Gliomas: Using Molecular Classifiers to Optimize Clinical Management

Jennie W. Taylor, MD;Andrew S. Chi, MD, PhD;Daniel P. Cahill, MD, PhD

June 15th 2013

We review the current data regarding the prognostic and predictive value of IDH mutation and 1p/19q codeletion in gliomas. We also discuss possible management algorithms using these biomarkers to tailor surgical and adjuvant therapy for specific diffuse gliomas.